![Bilal Arif](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bilal Arif
Chief Tech/Sci/R&D Officer at SAREPTA THERAPEUTICS, INC.
Net worth: 280 850 $ as of 30/06/2025
Profile
Bilal Arif currently works at Sarepta Therapeutics, Inc., as Chief Technical Operations Officer & Executive VP from 2022.
Mr. Arif also formerly worked at Momenta Pharmaceuticals, Inc., as Vice President-Technical Operations from 2017 to 2019 and Shire Plc, as Vice President-Technical Operations from 2015 to 2017.
Mr. Arif received his undergraduate degree from McGill University, graduate degree from Tufts University, Masters Business Admin degree from Instituto de Empresa SL, and undergraduate degree from Western New England University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/04/2025 | 16,424 ( 0.02% ) | 280 850 $ | 30/06/2025 |
Latest news about Bilal Arif
Bilal Arif active positions
| Companies | Position | Start |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2022 |
Former positions of Bilal Arif
| Companies | Position | End |
|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2019 |
| SHIRE | Chief Tech/Sci/R&D Officer | 01/03/2017 |
Training of Bilal Arif
Tufts University | Graduate Degree |
McGill University | Undergraduate Degree |
Instituto de Empresa SL | Masters Business Admin |
Western New England University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Bilal Arif
